Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giampaolo Merlini

Showing results (61-70 of 460) with videos related to

Pageof 46
Sort By:
The American Journal of Medicine|January 26, 2022
Future Developments in Light Chain Amyloidosis ManagementMario Rodriguez, Daniel Lenihan, Giampaolo Merlini
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 29, 2016
Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditionsPaolo Milani, Giovanni Palladini, Giampaolo Merlini
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 12, 2022
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic AmyloidosisMario Nuvolone, Alice Nevone, Giampaolo Merlini
British Journal of Haematology|February 4, 2020
A powerful oral triplet for AL amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Haematologica|November 21, 2007
Bortezomib in the treatment of AL amyloidosis: targeted therapy?Roberto Sitia, Giovanni Palladini, Giampaolo Merlini
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2018
Light Chain AmyloidosisPaolo Milani, Giampaolo Merlini, Giovanni Palladini
Clinical Chemistry and Laboratory Medicine|April 23, 2003
Guidelines for the analysis of Bence Jones proteinMariastella Graziani, Giampaolo Merlini, Concetta Petrini, et al.
Expert Review of Cardiovascular Therapy|October 27, 2015
Novel strategies for the diagnosis and treatment of cardiac amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Expert Review of Hematology|January 9, 2018
New concepts in the treatment and diagnosis of amyloidosisPaolo Milani, Giovanni Palladini, Giampaolo Merlini
Hemasphere|January 25, 2020
Here to Stay: Biosimilars in HematologyJohn Gribben, Giampaolo Merlini, Anton Hagenbeek
Pageof 46

Showing results (61-70 of 460) with videos related to

Sort By:
Pageof 46
The American Journal of Medicine|January 26, 2022
Future Developments in Light Chain Amyloidosis ManagementMario Rodriguez, Daniel Lenihan, Giampaolo Merlini
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|July 29, 2016
Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditionsPaolo Milani, Giovanni Palladini, Giampaolo Merlini
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 12, 2022
Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic AmyloidosisMario Nuvolone, Alice Nevone, Giampaolo Merlini
British Journal of Haematology|February 4, 2020
A powerful oral triplet for AL amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Haematologica|November 21, 2007
Bortezomib in the treatment of AL amyloidosis: targeted therapy?Roberto Sitia, Giovanni Palladini, Giampaolo Merlini
Mediterranean Journal of Hematology and Infectious Diseases|March 14, 2018
Light Chain AmyloidosisPaolo Milani, Giampaolo Merlini, Giovanni Palladini
Clinical Chemistry and Laboratory Medicine|April 23, 2003
Guidelines for the analysis of Bence Jones proteinMariastella Graziani, Giampaolo Merlini, Concetta Petrini, et al.
Expert Review of Cardiovascular Therapy|October 27, 2015
Novel strategies for the diagnosis and treatment of cardiac amyloidosisGiovanni Palladini, Paolo Milani, Giampaolo Merlini
Expert Review of Hematology|January 9, 2018
New concepts in the treatment and diagnosis of amyloidosisPaolo Milani, Giovanni Palladini, Giampaolo Merlini
Hemasphere|January 25, 2020
Here to Stay: Biosimilars in HematologyJohn Gribben, Giampaolo Merlini, Anton Hagenbeek
Pageof 46